Package 72572-020-01
Brand: azacitidine
Generic: azacitidinePackage Facts
Identity
Package NDC
72572-020-01
Digits Only
7257202001
Product NDC
72572-020
Description
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (72572-020-01)
Marketing
Marketing Status
Brand
azacitidine
Generic
azacitidine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "e2e6729f-6e81-476f-af63-82c094d4f6ee", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0372572020015"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["2d15b3ec-ed08-48c6-a400-34e55974afad"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Civica, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (72572-020-01)", "package_ndc": "72572-020-01", "marketing_start_date": "20250912"}], "brand_name": "Azacitidine", "product_id": "72572-020_e2e6729f-6e81-476f-af63-82c094d4f6ee", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "72572-020", "generic_name": "Azacitidine", "labeler_name": "Civica, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA212580", "marketing_category": "ANDA", "marketing_start_date": "20240516", "listing_expiration_date": "20261231"}